Belantamab Mafodotin as Part of the Implementation Tender - 145036582

Procurement Summary

Country: Poland

Summary: Belantamab Mafodotin as Part of the Implementation of the B.54 Drug Program Treatment of Patients with Plasmacytic Myeloma - 1 Product Package

Deadline: 21 Aug 2026

Posting Date: 13 Jul 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 145036582

Document Ref. No.: 480494-2026

Competition: ICB

Financier: Other Funding Agencies

Purchaser Ownership: Public

Tender Value: Refer Document

CPV Classification

33600000 - Pharmaceutical products

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_detailsLogin to see details

Tender Details

Package No. 1 Belantamab mafodotin as part of the implementation of Drug Program B.54 Treatment of myeloma patients plasma cell - 1 assortment package Doc Title: Belantamab mafodotin as part of the implementation of the B.54 Drug Program Treatment of patients with plasmacytic myeloma - 1 assortment package Contract Type: supplies
Document Type: Contract Notice Reference Number: DZP/182/2026 Contract Type: supplies Authority Type: eu-ins-bod-ag Doc Title: Belantamab mafodotin as part of the implementation of the B.54 Drug Program Treatment of patients with plasmacytic myeloma - 1 package asortymentowy Dispatch Date: 2026-07-10 Publish Date: 2026-07-13 Submission Date: 2026-08-21

Documents

 Tender Notice